Photo by finnnyc from unsplash
Cryptococcal meningitis (CM) is increasingly recognised in human immunodeficiency virus (HIV)‐uninfected patients with high mortality. The efficacy and safety profiles of induction therapy with high‐dose fluconazole plus flucytosine remain unclear. Click to show full abstract
Cryptococcal meningitis (CM) is increasingly recognised in human immunodeficiency virus (HIV)‐uninfected patients with high mortality. The efficacy and safety profiles of induction therapy with high‐dose fluconazole plus flucytosine remain unclear.
Keywords:
cryptococcal meningitis;
induction therapy;
immunodeficiency virus;
therapy high;
high dose;
human immunodeficiency
Journal Title: Mycoses
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Mycoses
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!